“Hormone therapy for prostate cancer associated with greater risk of dementia” – Statnews

by Shayla Love | Statnews.com

“The leading treatment for prostate cancer may, in the longer term, increase a person’s risk for dementia, a new study finds.

ALZHEIMERS DISEASE BRAINA section of a human brain with Alzheimer’s disease is on display at the Museum of Neuroanatomy at the University at Buffalo, in Buffalo, N.Y., Oct. 7, 2003. (AP Photo/David Duprey)

“The retrospective study, published in JAMA Oncology Thursday, analyzed almost a decade’s worth of medical records and found that men with prostate cancer who are treated with androgen deprivation therapy (ADT) are twice as likely to develop dementia, including Alzheimer’s, within five years, compared to prostate cancer patients who do not receive testosterone-lowering therapies.”

Read this Statnews.com article in its entirety, click here.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: